Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mannkind Corp (NASDAQ:MNKD)

Friday’s trading has closed, but MNKD is being traded in the after-hours session. After-Hours quote »
0.9841
Delayed Data
As of 4:00pm ET
 +0.0641 / +6.97%
Today’s Change
0.64
Today|||52-Week Range
7.32
-32.13%
Year-to-Date

Today’s Trading

Previous close0.92
Today’s open1.00
Day’s range0.92 - 1.01
Volume2,751,707
Average volume (3 months)7,232,445
Market cap$394.4M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+20.31%
Earnings growth (this year)+46.50%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.14+4.05%
OMEROmeros Corp+0.49+4.65%
TRVNTrevena Inc+0.21+2.75%
ACRSAclaris Therapeutics...-0.45-2.26%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 16, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$198.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Operating Officer
Juergen A. Martens
Corporate headquarters
Valencia, California

Forecasts

Partner Offers